Project Grant R01AG083580
Award Date 7/15/24
Completion Date 3/31/29
Dollars Obligated $3.9M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Salt Lake City, UT 84112, USA
Similar Awards
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of Rochester provides $308,000 in funding to develop and pilot test a shared decision-making (SDM) tool for surgeons to use when discussing major colorectal surgery with frail older adult patients. The goal is to improve communication and decision-making in this vulnerable patient population that experiences higher complication rates and impacts to quality of life from such...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded a $393,750 Project Grant to the University of California, Los Angeles (UCLA) on September 22, 2025, under the Aging Research program (CFDA 93.866). This prospective cohort study aims to evaluate how aggressive cancer treatments—including systemic chemotherapy, chemoradiotherapy, and immunotherapy—impact physical function in older adults (aged 60+) with gastroesophageal cancer. The research will deliver...
- This Project Grant award, provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), will fund a study to evaluate the impact of social determinants of health (SDOH) on early-onset colorectal cancer (EOCRC) diagnosis, treatment delays, and survival, with a focus on underserved populations in Kentucky and Georgia. The $192,610 award will support a 2-year epidemiologic study that aims to elucidate the relationship between SDOH measures and...
- Federal Grant Award Summary The National Institute on Aging awarded a $423,750 Project Grant to Weill Medical College of Cornell University on August 15, 2025, under the Aging Research program (CFDA 93.866) to investigate the impact of biological age on surgical outcomes. The research will deliver a comprehensive analysis examining how preoperative biological age—specifically immunologic age and metabolic age—predicts one-year postoperative mortality and loss of independence following surgery in...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $624,000.00 to the University of Texas Health Science Center at Houston to explore a patient priorities care framework for improving breast cancer survivorship care for older women with multiple chronic conditions. The project aims to use this framework to identify patient priorities, incorporate them into treatment plans, and evaluate the feasibility and impact on treatment burden and quality...
- Federal Cooperative Agreement Summary The National Cancer Institute (NCI) awarded Medstar Health Research Institute Inc. a Cooperative Agreement valued at $1,351,734 on July 25, 2025, under the Cancer Cause and Prevention Research program (CFDA 93.393) to deliver practical geriatric assessment services in community oncology settings. The primary objective is to increase the implementation and utilization of geriatric assessment protocols among older cancer patients (age 65+) in community-based...
- The Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $811,443 to Beth Israel Deaconess Medical Center, Inc. to conduct a cluster randomized trial of a breast cancer treatment decision aid for women aged 70 and older with low-risk stage I breast cancer. The project aims to develop and evaluate a shared decision-making training program for breast surgeons and a decision aid to inform women over 70 about the benefits and harms of their treatment...
- Federal Project Grant Award Summary Mayo Clinic Arizona has been awarded $420,000 in project grant funding from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective September 15, 2025, through August 31, 2027. The award funds a longitudinal research study examining quality of life (QOL) and patient priorities among older adults with indolent non-Hodgkin lymphoma (INHL). The study will leverage an existing lymphoma cohort and direct patient narratives to...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded Massachusetts General Hospital a $1.72M Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) effective June 1, 2025, through April 30, 2030. This award funds a randomized controlled trial of TARGET-PC, a five-session palliative care intervention designed to improve end-of-life (EOL) care outcomes for patients with metastatic breast cancer (MBC) and poor prognosis. The study will utilize the EPIC...
- This $399,187 federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will support research at Virginia Commonwealth University to study the role of ATG16L1 isoforms in colorectal cancer health disparities. The key objectives are to: 1) Determine whether the ATG16L1 T300T isoform, which is more predominant in African Americans, promotes more aggressive colorectal tumor growth and metastasis compared to the A300A isoform found more in...